Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:category |
vaccine
|
| gptkbp:clinicalTrialPhase |
ongoing as of 2024
|
| gptkbp:containsSerotype |
24 serotypes of Streptococcus pneumoniae
|
| gptkbp:developedBy |
gptkb:Pfizer
|
| gptkbp:fullName |
24-valent pneumococcal conjugate vaccine
|
| https://www.w3.org/2000/01/rdf-schema#label |
PCV24
|
| gptkbp:intendedUse |
prevention of invasive pneumococcal disease
|
| gptkbp:protectedBy |
pneumococcal disease
|
| gptkbp:relatedTo |
gptkb:PCV13
gptkb:PCV20 |
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:Streptococcus_pneumoniae
|
| gptkbp:valency |
24
|
| gptkbp:bfsParent |
gptkb:Vaxcyte
|
| gptkbp:bfsLayer |
7
|